Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HSV entry receptors are a group of cellular proteins that facilitate the binding, fusion, and penetration of herpes simplex virus into host cells. The major known HSV entry receptors include nectin-1 and nectin-2 (immunoglobulin superfamily adhesion molecules), HVEM (a member of the tumor necrosis factor receptor family), and 3-O-sulfated heparan sulfate. For HSV-1, PILRα has also been identified as a gB coreceptor in certain cell types. These receptors have non-redundant physiological functions in cell adhesion and immune modulation but are hijacked by HSV to mediate entry. The type of receptor used varies by cell type and viral strain, and multiple receptors may be used in parallel or redundantly. Antiviral strategies have focused on blocking these interactions, but their physiological roles complicate direct targeting.
Competitive inhibition of viral attachment or fusion (soluble receptors/antibodies block access to cellular receptors) Preventing conformational change in viral glycoproteins required for membrane fusion and entry Inhibiting virus spread and cell-cell fusion
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HSV entry receptors.